GSK3B and Obesity: Moreover, under disease conditions such as obesity and diabetes, GSK3β-mediated MG53 phosphorylation is robustly enhanced, resulting in markedly diminished IR and IRS1 levels in the heart and skeletal muscle and exaggerated systemic insulin resistance (see below for further discussion).